Loading...
"My proposal now is to test a vaccine first on people who have been infected, and if you show some efficacy at this level, you might be able to go further to study uninfected people in a population with a high rate of infection."
"We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody."
"I am very puzzled by the fact that young people are getting infected again. They don't take precautions despite an enormous amount of information. It's like riding a race car at 200 kilometers an hour. Some people like the risk."
"Basic research is very useful, but it should be more geared toward application than it was before."
"It's clear that prevention will never be sufficient. That's why we need a vaccine that will be safe."